Skip to Main Content
TABLE 3

Comparison of clinical profiles between those normal control subjects with and without the Ala12 allele of the Pro12→Ala polymorphism of PPAR-γ

CharacteristicPro/ProPro/Ala + Ala/AlaP*
n 1,114 98 
M/F 474/640 43/55 0.998 
Age (years) 71.4 ± 8.0 (1,114) 71.2 ± 8.2 (98) 0.750 
BMI (kg/m222.4 ± 3.3 (1,034) 22.4 ± 3.4 (92) 0.881 
HbA1c (%) 5.0 ± 0.3 (944) 5.0 ± 0.3 (85) 0.676 
FPG (mg/dl) 94 ± 11 (913) 94 ± 10 (76) 0.595 
CharacteristicPro/ProPro/Ala + Ala/AlaP*
n 1,114 98 
M/F 474/640 43/55 0.998 
Age (years) 71.4 ± 8.0 (1,114) 71.2 ± 8.2 (98) 0.750 
BMI (kg/m222.4 ± 3.3 (1,034) 22.4 ± 3.4 (92) 0.881 
HbA1c (%) 5.0 ± 0.3 (944) 5.0 ± 0.3 (85) 0.676 
FPG (mg/dl) 94 ± 11 (913) 94 ± 10 (76) 0.595 

Data are n or means ± SD (n).

*

P values were obtained by the two-tailed Student’s t test.

Close Modal

or Create an Account

Close Modal
Close Modal